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cated that the  rib  gene was predominant in the invasive 
strains (11; 59%), followed by  bca  (5; 22%), alp2  (2; 9%), alp3 
 (1;  5%) and  epsilon  (1; 5%), while in colonizing strains the  alp2 
 gene was most common (10; 50%), followed by epsilon  (5; 
25%),  rib  (2; 10%),  bca  (2; 10%) and  alp3  (1; 5%). A statisti-
cally significant relationship was noted between the  rib gene 
and invasive GBS (p = 0.0329), whereas  alp2  was related to 
the colonizing strains  (p = 0.0495).  Conclusions: The inves-
tigated GBS isolates originating from infections in newborns 
and healthy neonates represented serotype III in more than 
half of the cases and differed from one another in terms of 
resistance to macrolides, ST type affiliation and the presence 
of genes encoding surface proteins from the Alp family. Fur-
ther comparative genetic research on a larger number of 
strains is necessary for epidemiological investigation and 
vaccine development.  © 2014 S. Karger AG, Basel 
 Introduction 
 Streptococcus agalactiae, also referred to as Lancefield 
group B streptococcus (GBS), is a significant pathogen in 
neonates and adults with predisposing conditions in the 
USA and Europe  [1, 2] . GBS in newborns can lead to ear-
ly-onset diseases or late-onset diseases. Early-onset dis-
eases develop during the first 7 days of life, while late-
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 Abstract 
 Objectives: The present study aimed to investigate the mo-
lecular characterization of  Streptococcus agalactiae (group B 
streptococcus; GBS) strains isolated from newborns with in-
vasive neonatal infections and healthy newborns in Poland. 
 Materials and Methods: Forty-two GBS isolates were char-
acterized by combining different typing methods, i.e. multi-
locus sequence typing (MLST), molecular serotyping and 
protein gene profiling.  Results: Using MLST, a total of 16 se-
quence types (STs) were identified, and among these, 11 
were clustered into the following 5 clonal complexes (CCs): 
CC23 (20; 49%), CC19 (7; 17%), CC17 (4; 10%), CC10 (4; 10%) 
and CC1 (1; 2%). A statistically significant relationship be-
tween ST-17 and invasive isolates (p = 0.0398) and ST-23 and 
colonizing strains (p = 0.0034) was detected. Moreover, 2 
novel STs were detected (ST-637 and ST-638). Molecular se-
rotyping showed that in the invasive isolates serotype III was 
predominant (11; 50%), followed by serotypes II (6; 27%), V 
(3; 14%) and Ia (2; 9%). In healthy newborns, serotype III was 
also dominant (12; 60%), followed by serotypes Ia (4; 20%), II 
(2; 10%), V (1; 5%) and Ib (1; 5%). Protein gene profiling indi-
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onset diseases occur after the first week to 90 days of age. 
The most frequent clinical form of neonatal GBS-caused 
infection is sepsis or pneumonia; a less frequent one is 
cerebrospinal meningitis  [3] .
 S. agalactiae colonizes the genitourinary and lower 
gastrointestinal tract in 10–40% of all pregnant women. 
Maternal colonization with GBS is the predominant risk 
factor for the development of invasive neonatal GBS dis-
ease  [1–3] . GBS strains are subdivided according to type-
specific capsular polysaccharides into 10 unique sero-
types (Ia, Ib and II–IX)  [2, 4] . This capsule has been rec-
ognized as one of the major virulence factors with an 
anti-phagocytic function  [1] . The GBS pathogenicity var-
ies between and within serotypes, with considerable vari-
ation in genetic content between strains. Particularly, the 
serotypes most often causing invasive infections in new-
borns are III, Ia and V  [2, 5] .
 The best-characterized GBS protein antigens, which 
are significant virulence factors, belong to the alpha-like 
protein (Alp) family. They are called alpha-C protein, 
Rib, Alp2, Alp3, Alp4 and epsilon (Alp1) and are encoded 
by the  bca,  rib,  alp2,  alp3,  alp4 and  epsilon/alp1 genes, re-
spectively  [6] . Examination of the protein gene profile in-
creases the potential for GBS subtyping  [7, 8] .
 Multilocus sequence typing (MLST) has been described 
to be able to identify the emergence and spread of GBS 
clones and to study their genetic population structure 
worldwide  [9–12] . Recently, the hypervirulent ST-17 clone, 
defined with the application of MLST and associated with 
late-onset diseases and a very high mortality rate in new-
borns with meningitis, has been of great interest  [10–13] .
 There is limited knowledge regarding the epidemiology 
and molecular characterization of  S. agalactiae strains iso-
lated from newborns in Poland and Central-Eastern Eu-
rope, mainly due to a lack of supervision of these infections 
and failure to collect strains derived from neonates. There-
fore, the aim of the present study was to determine and 
comparatively analyse the genotypes of GBS strains iso-
lated from early-onset diseases in newborns and colonized 
neonates in Poland using different typing methods, such as 
molecular serotyping, protein gene profiling, antibiotic re-
sistance phenotyping and gene profiling as well as MLST.
 Materials and Methods 
 Study Population and Collection of Specimens 
 S. agalactiae  strains were obtained from the collection of the 
Department of Bacteriology, Microbial Ecology and Parasitology 
of Jagiellonian University Medical College (Krakow, Poland) 
which was created from 2006 to 2010 within the framework of two 
projects financed by the Polish Ministry of Research and Higher 
Education [No. 3PO5E08425 (n = 27) and NN401042337 (n = 15)]. 
The samples were taken from 22 neonates with early-onset GBS 
disease as part of standard care, whereas samples from 20 healthy 
newborns were collected after receiving appropriate consent from 
their guardians. This study was approved by the Jagiellonian Uni-
versity Bioethical Committee.
 The GBS strains originated from 3 neonatal wards from South-
ern (n = 27), Central (n = 12) and Northern (n = 3) Poland. A 
single isolate per patient was allowed. Altogether, 42 strains were 
obtained from newborns aged less than 7 days; 22 of these were 
from neonates with early-onset GBS disease, and 20 strains were 
isolated from colonized neonates without any signs or symptoms 
of infection. In 22 newborns with invasive neonatal infections, 
blood cultures were performed using Peds Plus Bactec 9120 media 
(Becton Dickinson, USA). Healthy newborns were tested for GBS 
colonization by taking swabs from the oral cavity during suction 
and from the external ear at 24–48 h of age  [14] . The samples were 
placed in a non-nutrient Amies transport medium (Eurotubo, 
Spain) and within 2–4 h they were inoculated into a selective broth 
medium, i.e. 3 ml Todd-Hewitt broth (Difco, USA) supplemented 
with 8 μg/ml gentamicin and 15 μg/ml nalidixic acid (Oxoid, UK), 
and then incubated overnight at 37  °  C. Positive blood cultures and 
pre-incubated selective broth cultures were subcultured onto Co-
lumbia 5% sheep blood agar (Difco). The identification of GBS was 
performed first using a latex agglutination assay and an API STREP 
kit (bioMerieux, France). Molecular identification based on PCR 
with Sag59 and Sag190 species-specific primers (Genomed, Po-
land) for  S. agalactiae  was applied  [18] . The tested GBS strains had 
been previously investigated for the presence of the hypervirulent 
ST-17 clone as previously described  [13] .
 The characteristics of the serotypes were tested using serologi-
cal a Group B Streptococcus GBS Serotyping Kit (ESSUM, Swe-
den). To verify the method, detection of the genes encoding cap-
sular polysaccharides Ia, Ib and II–VIII was investigated using a 
multiplex PCR method with specific primers (Genomed) accord-
ing to Poyart et al.  [4] .
 Detection of the surface protein genes  alp2, alp3, alp4, bca, ep-
silon and rib  was investigated using a  multiplex  PCR with specific 
primers (Genomed) according to the procedure proposed by Cre-
ti et al.  [7] and Gherardi et al.  [2] . 
 For antibiotic resistance, the minimum inhibitory concentra-
tions (MIC) of penicillin, ampicillin, erythromycin, clindamycin 
and vancomycin were evaluated using Etest (Oxoid) as recom-
mended by EUCAST  [15] . The macrolide resistance phenotypes 
cMLS B (constitutive), iMLS B (inducible) and M were determined 
using a double-disc test with erythromycin (15 μg) and clindamy-
cin (2 μg) (Oxoid). The  erm (A), erm (B ) ,  erm (C) and  mef (A/E) re-
sistance determinants were detected by multiplex PCR with 4 ad-
equate pairs of primers (Genomed) according to Sutcliffe et al. 
 [16] . 
 MLST analysis was performed as described by Jones et al.  [10] 
using oligonucleotide primer pairs (Genomed) specific for the 7 
housekeeping loci selected for GBS MLST. An online database 
(http://pubmlst.org/sagalactiae) was used to assign alleles to the 7 
loci and each isolate was defined by their sequence type (ST). The 
eBURST program was used to group isolates into clonal complex-
es (CCs) whose members shared at least 6 of the 7 MLST loci  [17] ; 
otherwise, an ST was considered a singleton. Novel alleles of the 
housekeeping genes were amplified and sequenced twice and these 
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profiles were named ‘new’ and added to the MLST database with 
a new ST number.
 The potential relationship between invasive or colonizing GBS 
isolates and STs, CCs or serotypes was analysed. 
 Statistical Analysis 
 For statistical analysis of the frequencies and probability of co-
incidence, a χ 2 test was used. When data were insufficient for the 
test demands, a G 2 (likelihood ratio test) was used. Comparison of 
the antibiotic resistance between invasive and colonizing strains 
was made with a Wilcoxon test. p < 0.05 was considered statisti-
cally significant. Analyses were conducted using the SAS 9.1 pack-
age and SAS Enterprise Guide 3.0 (SAS Institute Inc., Cary, N.C., 
USA). 
 Results 
 Serotypes of Neonatal GBS Strains 
 In the group of 22 invasive GBS isolates, serotype III 
was predominant (11; 50%), followed by serotypes II (6; 
27%), V (3; 14%) and Ia (2; 9%). In the 20 healthy new-
borns colonized by GBS, serotype III was also predomi-
nant (12; 60%), followed by serotypes Ia (4; 20%), II (2; 
10%), V (1; 5%) and Ib (1; 5%). In the study population, 
serotypes IV and VI–VIII were not identified. No signifi-
cant differences in serotype distribution were noted be-
tween the study groups of newborns ( table 1 ).
 Surface Protein Genes of Neonatal GBS Strains 
 One type of surface protein gene from the Alp family 
was found in each strain. In the invasive GBS isolates,  rib 
was predominant (13; 58%), followed by  bca (5; 23%), 
alp2 (2; 9%), alp3 (1; 5%) and  epsilon (1; 5%). The most 
common gene in the colonizing GBS strains was  alp2 (10; 
50%), followed by epsilon (5; 25%),  rib (2; 10%),  bca (2; 
10%) and  alp3 (1; 5%). In this population of GBS isolates, 
the  alp4 gene was not found. Moreover, the relationships 
between the capsular polysaccharide serotype and surface 
protein genes in invasive and colonizing isolates were 
noted ( fig. 1 ). A statistically significant relationship was 
observed between the  rib gene and invasive GBS strains 
with the III serotype (χ 2 = 4.549; p = 0.0329) and the  alp2 
gene and colonizing GBS isolates with the III serotype
(χ 2 = 3.630; p = 0.0495) ( table 1 ).
 Resistance of the GBS Strains 
 The values of MIC 50 and MIC 90 for penicillin, ampicil-
lin, erythromycin, clindamycin and vancomycin are giv-
en in  table 2 . All GBS isolates were susceptible to penicil-
lin, ampicillin and vancomycin. Resistant strains were 
found only in neonates with infections; 6 (27%) of these 
invasive isolates were resistant to erythromycin (G 2 = 
 Table 1.  Characteristics of invasive and colonizing GBS strains iso-
lated from neonates according to capsular serotype, Alp family 
gene and resistance determinant
Investigated 
features
 GBS strain type Total
in vasive 
strains
colonizing strains
Capsular serotype
Ia 2 (9) 4 (20) 6 (14)
Ib 0 (0) 1 (5) 1 (2)
II 6 (27) 2 (10) 8 (19)
III 11 (50) 12 (60) 23 (55) 
V 3 (14) 1 (5) 4 (10)
Total 22 (100) 20 (100) 42 (100)
Gene from the Alp family
alp2 2 (9) 10 (50) (p = 0.0495)* 12 (28)
alp3 1 (5) 1 (5) 2 (5)
bca 5 (23) 2 (10) 7 (17)
epsilon 1 (5) 5 (25) 6 (14)
rib 13 (58) 2 (10) (p = 0.0329)* 15 (36)
Total 22 (100) 20 (100) 42 (100)
Erythromycin resistance gene
ermB 6 (27) 0 (0) (p = 0.0038)* 6 (14)
Total 22 (100) 20 (100) 42 (100)
Values represent n (%).  * Statistically significant (p < 0.05).
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 Fig. 1. Diversity of surface protein genes from the Alp family 
among the particular serotypes in GBS strains isolated from new-
borns with invasive neonatal infections and healthy newborns. 
Col = Colonizing GBS; Inv = invasive GBS. 
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8.356; p = 0.0038) and 5 (23%) were resistant to clindamy-
cin (G 2 = 6.823; p = 0.0090). Macrolide resistance was not 
attributable to a single serotype, ST or CC. Among the 6 
resistant strains, the cMLS B phenotype was detected in 5 
(83%) cases and iMLS B in 1 (17%). The  erm B gene was 
present in all 6 macrolide-resistant strains. The  erm A, 
 erm C and  mef (A/E)  genes were not detected in the col-
lected strains.
 MLST Analysis 
 A total of 16 STs were identified for 42 of the examined 
strains. Among these, 11 were clustered into 5 CCs, the 
most prevalent of which was CC23 (20; 49%), followed by 
CC19 (7; 17%), CC17 (4; 10%), CC10 (4; 10%) and CC1 
(1; 2%). The singletons identified were ST-22, ST-255 and 
ST-410; moreover, 2 novel STs were detected, i.e. ST-637 
and ST-638 ( table 3 ).
 A statistically significant variability in the number of 
STs in invasive isolates (n = 13) in relation to the coloniz-
ing strains (n = 6) was noted (χ 2 = 10.3; p = 0.0013). A 
diverse population was found among the GBS isolates, 
with some exceptions, i.e. that ST-17 occurred only in in-
vasive isolates with serotype III while ST-23 was more 
frequent in colonizing strains with serotype III ( table 3 ; 
 fig. 2 ).
 Variability in the serotype distribution was observed 
within some of the STs. For instance, of the 16 isolates 
identified as ST-23, 11 were serotype III and 5 were sero-
type Ia. Similarly, of the 5 isolates identified as ST-19, 3 
were serotype II and 2 were serotype III. Conversely, all 
ST-17 isolates represented serotype III, and all ST-12 iso-
lates belonged to serotype II.
 Discussion 
 Our study demonstrated that the population structure 
of GBS isolates in Polish neonates is similar to the GBS 
population structures in other European countries and 
around the world  [18, 19] .  S. agalactiae is a genetically 
diverse organism. Therefore, a combination of several 
molecular typing methods should be considered to pro-
vide a better understanding of the pathogenesis and epi-
demiology of GBS isolates  [20] . Numerous epidemiolog-
ical investigations have shown that the serotype distribu-
tion of GBS varies both geographically and over time  [2, 
4, 5] . In our study, serotype III was predominant in both 
study groups of neonates and represented 50% of the in-
vasive GBS isolates and 60% of isolates from newborn 
colonization. Other serotypes in invasive strains were in 
sequence II, V and Ia and for colonizing strains Ia, II, V 
and Ib. When comparing the present results with previ-
ous investigations on 169 GBS-positive pregnant women 
in whom serotype III was predominant in 35% of cases, 
followed by Ia, V, II, Ib and IV, we concluded that the cur-
rent reported results are quite similar but with varying 
degrees of participation of individual serotypes  [8] . The 
data obtained in relation to the serotype distribution cor-
respond with the results of other European countries 
where serotypes Ia, II, III and V have been found in 80–
90% of all clinical isolates, while serotypes VI and VII–IX 
have seldom been observed  [2, 5] . Fluegge et al.  [21] not-
ed that serotype III was the most common in invasive and 
non-invasive GBS strains isolated from newborns, and it 
was significantly predominant in invasive isolates.
 Surface protein antigens play an important role in the 
pathogenesis of GBS infection, and several of these anti-
gens have been suggested as components of GBS conju-
gate vaccines  [1, 6] .  Protein gene profiling increases the 
potential for GBS subtyping  [7] . The association of the  rib 
gene and serotype III has been confirmed by several re-
ports  [2, 21] . In our study, the percentages of  rib- positive 
isolates within serotype III strains varied significantly; in 
invasive isolates, the  rib gene was detected in 59% of cas-
es, while in colonizing strains  rib was identified in 10% of 
cases. These results agree with previous studies which 
demonstrated that the  rib gene was associated with inva-
sive strains  [22] . These findings may be evidence of an 
 Table 2.  Distribution of MIC in invasive and colonizing GBS 
strains from neonates
Antibiotics MIC MIC for colonizing 
strains (n = 20),
μg/ml
MIC for invasive 
strains (n = 22),
μg/ml
Penicillin MIC50 0.06 0.06
MIC90 0.12 0.12
Ampicillin MIC50 0.06 0.06
MIC90 0.078 0.06
Erythromycin MIC50 0.06 0.06
MIC90 0.06 256 (p = 0.0380)*
Clindamycin MIC50 0.06 0.06
MIC90 0.06 256 (p = 0.0090)*
Vancomycin MIC50 0.5 0.5
MIC90 1 1 * Statistically significant (p < 0.05).
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important role of the Rib protein in invasive disease  [21, 
23] . Moreover, a statistically significant relationship be-
tween  alp2- positive isolates within serotype III strains 
 and colonizing status was detected. The noted relation-
ship is interesting and has not been described by other 
investigators. In contrast, the most common Alp gene in 
GBS strains isolated from pregnant women from our pre-
vious report was  epsilon, and it accounted for 26% of all 
cases  [8] .
 For many years, GBS remained susceptible to penicil-
lin, the recommended drug for the treatment and pro-
phylaxis of infections caused by GBS. In the USA, for pa-
tients allergic to penicillin, the alternative drugs accord-
ing to the 2002 recommendation of the Centers for 
Disease Control and Prevention (CDC) were macrolides 
and lincosamides  [24] . However, in 2006 in the USA, 
24.5% of invasive and 41.9% of colonizing GBS isolates 
were erythromycin resistant  [26] . Due to this high level of 
erythromycin resistance, the CDC did not recommend 
erythromycin anymore in 2010  [25] . In Europe, the eryth-
romycin resistance in GBS isolates from newborns and 
adults ranged from 10% in Portugal  [27] to 16% in Poland 
[28] and 16.5% in Italy  [2] . In the examined population 
of newborns, resistant strains were found only in neo-
nates with invasive infections; 27% of these were resistant 
to erythromycin and 23% were resistant to clindamycin. 
Our results indicate a very high percentage of resistant 
strains in the study group of neonates.
 Two principal resistance mechanisms are described 
for GBS: methylation of 23S ribosomal RNA, determined 
by  erm genes, and active drug efflux by pumps encoded 
by  mef genes. Expression of  erm genes is described as the 
MLS B phenotype (cMLS B constitutive; iMLS B inducible), 
while expression of  mef genes is called the M phenotype 
 Table 3.  Characteristic of the CCs and STs of invasive and colonizing GBS strains isolated from neonates accord-
ing to virulence factors (serotypes and Alp genes) and resistance determinants (ermB gene)
CC ST  Strain type, n Capsular 
serotype
Gene from 
the Alp 
family
Erythromycin 
resistance 
determinantc olonizing invasive
CC1 (1) ST-1 (1) 0 1 V (1) alp3 (1)
CC10 (4) ST-10 (1) 0 1 II (1) bca (1)
ST-12 (2) 1 1 II (2) bca (2)
ST-358 (1) 0 1 III (1) rib (1) ermB (1)
CC17 (4) ST-17 (4) 0 4 (p = 0.0398)* III (4) rib (4)
CC19 (7) ST-19 (5) 2 3 II (3)
III (2) rib (5) ermB (2)
ST-106 (1) 0 1 II (1) bca (1)
ST-286 (1) 0 1 III (1) rib (1)
CC23 (20) ST-23 (16) 13 3 (p = 0.0034)* Ia (5) alp2 (10)
III (11) alp3 (1)
epsilon (5)
ST-220 (3) 0 3 Ia (1) bca (1)
III (1) rib (2)
V (1)
ST-249 (1) 1 0 III (1) alp2 (1)
Singleton (5) ST-22 (1) 0 1 II (1) bca (1) ermB (1)
ST-255 (1) 1 0 Ib (1) epsilon (1)
ST-410 (1) 0 1 III (1) rib (1) ermB (1)
ST-637 (1)** 1 0 V (1) bca (1)
ST-638 (1)** 0 1 V (1) rib (1) ermB (1)
Not tested (1) NT (1) 1 0 III (1) alp2 (1)
 Numbers in parentheses represent the number of isolates. * Statistically significant (p < 0.05). ** New sequence 
type.
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 [2] . Among our invasive strains, the cMLS B phenotype 
was predominant in 83% of cases, followed by iMLS B in 
17%, and the presence of the  erm B gene was detected in 
all of the cases. Similar results have been noted by other 
investigators. For example, Sadowy et al.  [9] reported that 
the most prevalent determinant of resistance was  erm B, 
usually located on the Tn3872-like transposon.
 MLST has become the conventional method for deter-
mining the population structure of GBS, and it has been 
applied to the molecular epidemiology of  S. agalactiae  in-
fections by several investigators  [9, 10, 19] . To date, 5 
main CCs, i.e. CC1, CC10, CC23, CC19 and CC17, have 
been identified, emphasizing the diversity of  S. agalactiae 
 in humans  [9, 19] . In our study, approximately 86% of the 
invasive isolates and 85% of the colonizing strains could 
be grouped into 1 of the 5 CCs (CC23, CC19, CC17, CC10 
or CC1). These 5 CCs have also been highly widespread 
in other GBS collections, i.e. from Italy  [2] , Sweden  [29] , 
the USA  [19] and Taiwan  [30] . Sadowy et al.  [9] reported 
that GBS isolates represented 30 different STs grouped 
into 4 CCs, i.e. CC1, CC17, CC19, and CC23, that consti-
tuted 98.2% of all the studied isolates.
 In our study, CC17 occurred only in invasive isolates 
with serotype III and rib, while CC23 was more frequent-
ly present in colonizing strains with serotype III and alp2. 
Similarly, a study by Bohnsack et al.  [19] demonstrated 
that CC17 was strongly correlated with serotype III and 
invasive infection, whereas CC23 strains were predomi-
nant in 98% of cases among serotype Ia strains that colo-
nize human neonates. In contrast, in a German-based 
study, MLST of non-invasive serotype III isolates from 
neonates in whom sepsis was suspected but whose blood 
cultures were sterile revealed that ST-389, which belongs 
to CC19, was predominant  [21] .
 The hypervirulent clone ST-17 represents successful 
invasive clones which belong to the complex CC17 and 
are responsible for causing invasive infections in new-
borns, and it is now considered the most important type 
of ST worldwide  [12, 13, 18, 29] . This clone is isolated 
from neonates with both early-onset diseases and late-
onset diseases and the majority of cases present in the 
form of meningitis, with a high mortality rate (70%)  [19, 
29] . Straková et al.  [12] identified the ST-17 clone in 85% 
of cerebrospinal fluid isolates (6 out of 7) but only in 32% 
V
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 Fig. 2. Diversity of STs among particular 
serotypes in GBS strains isolated from 
newborns with invasive neonatal infec-
tions and healthy newborns. 
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of blood isolates. In our study, the hypervirulent clone 
ST-17 was detected in 4 cases (18%) of early sepsis devel-
oping during the first day of life.
 Similarly to the findings of Luan et al.  [29] , within 
some of the STs, we noticed variability in the serotype 
distribution. For example, out of the 16 isolates identified 
as ST-23, 11 were serotype III and 5 were serotype Ia; 
moreover, 3 out of 3 ST-220 isolates expressed 3 different 
serotypes, i.e. Ia, III and V. These results confirmed that 
the horizontal transfer of capsular genes exists in the GBS 
population. Indeed, the level of capsular switching ap-
pears to be high in S. agalactiae strains and the exchange 
of capsule polysaccharide genes between isolates with dif-
ferent genetic backgrounds occurs without restrictions to 
certain genetic lineages  [29] .
 A limitation of our study is the small number of col-
lected strains from neonates. However, due to a com-
plete lack of similar analyses from our country, we 
strongly believe that our results are unique from the 
Polish perspective and support important information 
about neonatal GBS isolates. Admittedly, Sadowy et al. 
 [9] conducted studies on the population structure of 
GBS in Poland, but the analysis involved strains iso-
lated from different clinical materials, mainly from 
adults. 
 Conclusion 
 The investigated GBS isolates originating from infec-
tions in newborns and healthy neonates represented sero-
type III in more than a half of the cases and differed from 
one another in terms of resistance to macrolides, ST type 
affiliation and the presence of genes encoding surface pro-
teins from the Alp family. Further comparative genetic 
research on a larger number of strains is necessary for ep-
idemiological investigation and vaccine development.
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